As a new longitudinal study shows a definitive connection between the Epstein-Barr virus and multiple sclerosis, research turns to vaccines, new treatments — and the further roots of what causes the disease.
Clinical trials for disease-modifying therapy for Alzheimer’s disease are underway.
New retrospective research indicates depression management may lower mortality rates among those with MS.
Deep Brain Stimulation at Some Frequencies May Be as Effective as Medication for Parkinson’s Disease
A new study offers hope for improving DBS treatments.
In 2021, scientists continue to learn about diagnosis, treatment and prevention of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Three new studies show protein biomarkers can identify Alzheimer’s Disease years before people have symptoms.
Researchers have discovered nontraditional techniques to identify Parkinson’s disease as early as possible, offering hope for patients seeking answers during the early stages of this difficult-to-diagnose neurological condition.
Researchers with Rice University develop the first neural stimulator powered by magnetic energy.
Alzheimer’s disease, irritable bowel disease and osteoarthritis place a heavy burden on patients, caregivers and the healthcare system.
Ischemic stroke and transient ischemic attack (TIA) have grown more prevalent in young and middle-aged adults during the past decade. According to research led by the University of North Carolina School of Medicine, post-traumatic stress disorder may be to blame.
- 1 of 7
- next ›